2019
DOI: 10.26577/ijbch-2019-v2-10
|View full text |Cite
|
Sign up to set email alerts
|

The plasma levels of hsa-miR-19b-3p, hsa-miR-125b-5p and hsa-miR-155b-5p in NSCLC patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 1 publication
0
1
0
Order By: Relevance
“…The level of freecirculating microRNA hsa-miR-19b-3p was significantly higher in groups of patients with lung cancer compared with healthy individuals. Our results indicate that the detection of hsa-miR-19b-3p levels in blood plasma can potentially be used as a non-invasive method for diagnosing lung cancer [58] and further identification of miRNAs as a specific marker of radon exposure becomes very relevant. However, a major disadvantage of this approach is the low specificity of the method based on freecirculating miRNAs and the inability to obtain miRNAsdirectly from tumor tissue.…”
Section: Role Of Exosomal Microrna In Diagnosis Of Lung Cancermentioning
confidence: 92%
“…The level of freecirculating microRNA hsa-miR-19b-3p was significantly higher in groups of patients with lung cancer compared with healthy individuals. Our results indicate that the detection of hsa-miR-19b-3p levels in blood plasma can potentially be used as a non-invasive method for diagnosing lung cancer [58] and further identification of miRNAs as a specific marker of radon exposure becomes very relevant. However, a major disadvantage of this approach is the low specificity of the method based on freecirculating miRNAs and the inability to obtain miRNAsdirectly from tumor tissue.…”
Section: Role Of Exosomal Microrna In Diagnosis Of Lung Cancermentioning
confidence: 92%